




Searching News Database: Napo Pharmaceuticals
HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
HSMN NewsFeed - 14 Mar 2007
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment